TICKERNOMICS Sign up
Last Update: 2023-12-23 06:04:19
Nemaura Medical Inc. ( NMRD ) https://nemauramedical.com
0.17USD
Sector:
Healthcare
Industry:
Medical Devices
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-91.00%
NMRD
SPY
30.72%
-96.08%
NMRD
SPY
112.82%
-98.30%
NMRD
SPY
201.04%
NMRD
0.00%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
4.91
42.00
0.11
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-0.55
-4.25
-0.31
-193.60
0.00
-5.36
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
132.00
195.15
252.68
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
6.6752
-49.79
-219.00
0.68
Other Earnings and Cash Flow Stats:
Nemaura Medical Inc. ( NMRD ) Net Income TTM ($MM) is -14.27
Nemaura Medical Inc. ( NMRD ) Operating Income TTM ($MM) is -8.57
Nemaura Medical Inc. ( NMRD ) Owners' Earnings Annual ($MM) is 0.00
Nemaura Medical Inc. ( NMRD ) Current Price to Owners' Earnings ratio is 0.00
Nemaura Medical Inc. ( NMRD ) EBITDA TTM ($MM) is -8.09
Nemaura Medical Inc. ( NMRD ) EBITDA Margin is 252.68%
Capital Allocation:
Nemaura Medical Inc. ( NMRD ) has paid 0.00 dividends per share and bought back -4.796536 million shares in the past 12 months
Nemaura Medical Inc. ( NMRD ) has increased its debt by 0.175116 million USD in the last 12 months
Capital Structure:
Nemaura Medical Inc. ( NMRD ) Interest-bearing Debt ($MM) as of last quarter is 38
Nemaura Medical Inc. ( NMRD ) Annual Working Capital Investments ($MM) are 2
Nemaura Medical Inc. ( NMRD ) Book Value ($MM) as of last quarter is -16
Nemaura Medical Inc. ( NMRD ) Debt/Capital as of last quarter is -243%
Other Balance Sheet Stats:
Nemaura Medical Inc. ( NMRD ) has 1 million in cash on hand as of last quarter
Nemaura Medical Inc. ( NMRD ) has 21 million of liabilities due within 12 months, and long term debt 20 as of last quarter
Nemaura Medical Inc. ( NMRD ) has 28 common shares outstanding as of last quarter
Nemaura Medical Inc. ( NMRD ) has 0 million USD of preferred stock value
Academic Scores:
Nemaura Medical Inc. ( NMRD ) Altman Z-Score is -14.57 as of last quarter
Nemaura Medical Inc. ( NMRD ) Piotroski Score is 2.00 as of last quarter
Corporate Governance:
Nemaura Medical Inc. ( NMRD ) largest shareholder is SIMPLEX TRADING, LLC owning 2814 shares at 0.00 ($MM) value
Mclarney Justin James(Chief Financial Officer) Bought 22293 shares of Nemaura Medical Inc. ( NMRD ) for the amount of $0.00 on 2022-01-31
48.30% of Nemaura Medical Inc. ( NMRD ) is held by insiders, and 7.76% is held by institutions
Nemaura Medical Inc. ( NMRD ) went public on 2016-03-04
Other Nemaura Medical Inc. ( NMRD ) financial metrics:
FCF:-9.67
Unlevered Free Cash Flow:-16.58
EPS:-0.17
Operating Margin:132.00
Gross Profit Margin:195.15
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:30.33
Beta:0.68
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About Nemaura Medical Inc. ( NMRD ) :
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.